Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Parkinson's Disease

Free Subscription 20.04.2026 1 Ann Neurol 1 Exp Brain Res 2 Exp Neurol 1 J Neurochem 8 Mov Disord 3 Neurobiol Dis 2 Neurochem Res 1 Neurol Genet 1 Neurologia (Engl Ed) 1 Neurology 1 Neuropsychology 1 Neurosci Lett 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. ZVAROVA P, van der Linden C, Li N, Butenko K, et al
   Multimodal Image Guidance in Subthalamic Deep Brain Stimulation for Parkinson's Disease.
   Ann Neurol. 2026 Apr 17. doi: 10.1002/ana.78206.
   PubMed         Abstract available
   
   

   
   Exp Brain Res

2. CHANG CL, Lin TK, Tsai CL
   Serum albumin and uric acid: biomarkers of neurocognitive and physical function in early Parkinson's disease.
   Exp Brain Res. 2026;244:94.
   PubMed        
   
   

   
   Exp Neurol

3. ZHANG S, An Y, Xu Y, Mi J, et al
   Transcranial magneto-acoustical stimulation regulates motor cortex-subthalamic nucleus neural activity to improve motor disorders in a Parkinson's disease mouse model.
   Exp Neurol. 2026 Apr 12:115763. doi: 10.1016/j.expneurol.2026.115763.
   PubMed         Abstract available
   
   
4. ALVAREZ-LUQUIN DD, Gonzalez-Fernandez RR, Ichikawa-Escamilla E, Torres-Velasco ME, et al
   Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets.
   Exp Neurol. 2026;402:115764.
   PubMed         Abstract available
   
   

   
   J Neurochem

5. SPERLICH CL, Stockwell BR, Farina M
   When Pathways Converge: Iron, Lipid Peroxidation, and alpha-Synuclein in Ferroptosis-Driven Dopaminergic Neurodegeneration.
   J Neurochem. 2026;170:e70438.
   PubMed         Abstract available
   
   

   
   Mov Disord

6. ABDI-SARGEZEH B, Liu T, Sharma A, Denison T, et al
   Pre-Beta Burst Dynamics in Parkinson's Disease: Distinguishing Signal from Artifact.
   Mov Disord. 2026 Apr 17. doi: 10.1002/mds.70317.
   PubMed        
   
   
7. MIRPOUR K, Choi JW, Pouratian N
   Is the Pre-Beta Burst Dip in Parkinson's Disease Biological or an Analytical Artifact?
   Mov Disord. 2026 Apr 16. doi: 10.1002/mds.70252.
   PubMed        
   
   
8. NATERA-VILLALBA E, Martinez-Fernandez R, Jimenez-Castellanos T, Rodriguez-Rojas R, et al
   Five-Year Follow-Up of Unilateral Focused Ultrasound Subthalamotomy for Parkinson's Disease.
   Mov Disord. 2026 Apr 15. doi: 10.1002/mds.70307.
   PubMed         Abstract available
   
   
9. NAGAO KJ, Perera T, Petoe M, Lee WL, et al
   Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson's Disease.
   Mov Disord. 2026 Apr 15. doi: 10.1002/mds.70318.
   PubMed         Abstract available
   
   
10. TORSO M, Tzaferou D, Valotti M, Hardwidge J, et al
    Diffusion Magnetic Resonance Imaging of Cortical Microstructure Differs in Nonmanifest and Manifest Genetic Parkinson's Disease.
    Mov Disord. 2026 Apr 13. doi: 10.1002/mds.70298.
    PubMed         Abstract available
    
    
11. GAN-OR Z
    Clinical Trials in GBA1-Associated Parkinson's Disease: A Need for Molecular Classification.
    Mov Disord. 2026 Apr 13. doi: 10.1002/mds.70328.
    PubMed        
    
    
12. SLINGERLAND S, van der Zee S, van Ijzendoorn SCD, Slomp AC, et al
    Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's Disease.
    Mov Disord. 2026 Apr 13. doi: 10.1002/mds.70292.
    PubMed         Abstract available
    
    
13. MACLEOD AD, McLernon DJ, Camacho M, Williams-Gray CH, et al
    Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence Cohorts.
    Mov Disord. 2026 Apr 11. doi: 10.1002/mds.70303.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

14. LOMBARDI G, Fiorillo L, Castelnovo A, Bertaina I, et al
    Dynamics of slow wave sleep in advanced Parkinson's disease: An entropy-based study.
    Neurobiol Dis. 2026 Apr 13:107395. doi: 10.1016/j.nbd.2026.107395.
    PubMed         Abstract available
    
    
15. MEIJER L, Lindberg MF, Hogrel G, Khor B, et al
    DYRK1A and Parkinson's disease, facts and hypotheses.
    Neurobiol Dis. 2026 Apr 14:107379. doi: 10.1016/j.nbd.2026.107379.
    PubMed         Abstract available
    
    
16. YAN WJ, Yang YL, Yan W, Tian SY, et al
    Histamine H4 receptor in neuroinflammation: Dual roles in multiple sclerosis and Parkinson's disease.
    Neurobiol Dis. 2026 Apr 15:107400. doi: 10.1016/j.nbd.2026.107400.
    PubMed         Abstract available
    
    

    
    Neurochem Res

17. TEIXEIRA IMM, Duque BR, da Costa MDR, da Silva ME, et al
    Resveratrol-Loaded Polymeric Nanoparticles Protect Against Rotenone-Induced Parkinsonian-Like Cellular Damage In Vitro: Association with NRF2/HMOX-1 Expression Changes.
    Neurochem Res. 2026;51:138.
    PubMed         Abstract available
    
    
18. LIU Y, Li H, Bai J
    Mitochondrial Fission and Fusion Disorders and Autophagy Abnormalities in Parkinson's Disease.
    Neurochem Res. 2026;51:136.
    PubMed        
    
    

    
    Neurol Genet

19. HONG S, Koretsky MJ, Lichtenberg J, Leonard HL, et al
    Parkinson Disease Pathogenic Variants: Cross-Ancestry Analysis and Microarray Data Validation.
    Neurol Genet. 2026;12:e200379.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

20. PAINOUS MARTI C, Pijuan Jimenez I, Bayes Rusinol A, Martinez Castrillo JC, et al
    The Parkinson's Real-World Impact Assessment (PRISM) project in the management and burden of Parkinson's disease in Spain.
    Neurologia (Engl Ed). 2026;41:501921.
    PubMed         Abstract available
    
    

    
    Neurology

21. YOO HS, Kim HK, Park M, Ahn SJ, et al
    Functional Reorganization of Corticostriatal Connectivity Across the Degree of Nigrostriatal Degeneration in Parkinson Disease.
    Neurology. 2026;106:e214812.
    PubMed         Abstract available
    
    

    
    Neuropsychology

22. MUKADAM N, Mahmood A, Cronin-Golomb A, DeGutis J, et al
    Subjective cognitive concerns and global metacognitive bias in prodromal Parkinson's and Parkinson's disease without cognitive impairment.
    Neuropsychology. 2026 Apr 16. doi: 10.1037/neu0001083.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

23. AUNG TL, Aung YW, Myint KS, Shi X, et al
    Dysregulation of mRNAs and hub genes in Parkinson's disease within post mortem substantia Nigra: using three methods differential expression genes analysis.
    Neurosci Lett. 2026 Apr 12:138607. doi: 10.1016/j.neulet.2026.138607.
    PubMed         Abstract available
    
    

    
    PLoS One

24. MAGALHAES JP, Landers MR, Scianni AA, Ribeiro MEBS, et al
    Effect of a 3-week program of cane training and use on gait of individuals with Parkinson's disease: Protocol for a randomized controlled trial.
    PLoS One. 2026;21:e0341248.
    PubMed         Abstract available
    
    
25. WALL C, McMeekin P, Hetherington V, Morris R, et al
    Retraining gait in Parkinson's Disease via a personalised app: A study protocol.
    PLoS One. 2026;21:e0346508.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum